PARP1/2 inhibition in a subset of triple negative breast cancer (TNBC) patient-derived tumor xenografts (PDX) identifies predictive biomarkers of response Meeting Abstract


Authors: Serra, V.; Cruz, C.; Bruna, A.; Ibrahim, Y. H.; Vivancos, A.; Vivancos, A.; Nuciforo, P.; Bellet, M.; Gómez, P.; Pérez, J. M.; Saura, C.; Vidal, M.; Serres, X.; Rueda, O. M.; Peg, V.; Caldas, C.; O'Connor, M. J.; Baselga, J.; Cortés, J.
Abstract Title: PARP1/2 inhibition in a subset of triple negative breast cancer (TNBC) patient-derived tumor xenografts (PDX) identifies predictive biomarkers of response
Meeting Title: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 76
Issue: 4 Suppl.
Meeting Dates: 2015 Dec 8-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2016-02-15
Language: English
ACCESSION: WOS:000375622400221
DOI: 10.1158/1538-7445.sabcs15-p4-07-04
PROVIDER: wos
Notes: Meeting Abstract: P4-07-04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga